Nitrogen

Basic Information

Item Value
DrugBank ID DB09152
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 61

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 16q24.1 microdeletion syndrome KG + DL
2 primary interstitial lung disease specific to childhood KG + DL
3 isolated pulmonary capillaritis KG + DL
4 congenital pulmonary lymphangiectasia KG + DL
5 benign neoplasm of adrenal gland KG + DL
6 malformation syndrome with odontal and/or periodontal component KG + DL
7 syndrome with a Dandy-Walker malformation as major feature KG + DL
8 isolated genetic hair shaft abnormality KG + DL
9 Ambras type hypertrichosis universalis congenita KG + DL
10 hypertrichosis (disease) KG + DL
11 mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies KG + DL
12 autosomal ichthyosis syndrome with fatal disease course KG + DL
13 pulmonary arteriovenous malformation (disease) KG + DL
14 Gaucher disease KG + DL
15 Steel syndrome KG + DL
16 pulmonary arterial hypertension associated with congenital heart disease KG + DL
17 pulmonary arterial hypertension associated with HIV infection KG + DL
18 pulmonary arterial hypertension associated with schistosomiasis KG + DL
19 pulmonary arterial hypertension associated with connective tissue disease KG + DL
20 pulmonary arterial hypertension associated with chronic hemolytic anemia KG + DL
21 hypophosphatasia KG + DL
22 citrullinemia, type II, adult-onset KG + DL
23 adult-onset citrullinemia type I KG + DL
24 acute neonatal citrullinemia type I KG + DL
25 Hurler syndrome KG + DL
26 polycystic kidney disease 3 with or without polycystic liver disease KG + DL
27 citrin deficiency KG + DL
28 Cushing disease due to pituitary adenoma KG + DL
29 renal-hepatic-pancreatic dysplasia KG + DL
30 exocrine pancreatic insufficiency KG + DL
31 Joubert syndrome with renal defect KG + DL
32 pituitary dwarfism KG + DL
33 pulmonary arterial hypertension KG + DL
34 thoracic malformation KG + DL
35 karyomegalic interstitial nephritis KG + DL
36 monosomy X KG + DL
37 syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy KG + DL
38 adult familial nephronophthisis-spastic quadriparesia syndrome KG + DL
39 Gaucher disease perinatal lethal KG + DL
40 growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant KG + DL
41 lysosomal storage disease with skeletal involvement KG + DL
42 adult Krabbe disease KG + DL
43 congenital anomaly of the great veins KG + DL
44 Tay-Sachs disease KG + DL
45 Scheie syndrome KG + DL
46 cholesterol metabolism disease KG + DL
47 primary bone dysplasia with increased bone density KG + DL
48 Krabbe disease KG + DL
49 autosomal dominant polycystic liver disease KG + DL
50 metachromatic leukodystrophy KG + DL

(Showing top 50 of 61 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.